GlobeNewswire Inc.··AlvotechIcelandic Biotech Alvotech Files 2025 Annual Report, Expands Global Biosimilar Footprint
Alvotech files 2025 Form 20-F, revealing operations across six continents as the Icelandic biosimilar developer pursues international market expansion.
ALVOALVOWbiotechForm 20-F